Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May 1;34(6):953-954.
doi: 10.1097/QAD.0000000000002480.

Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C co-infection

Affiliations
Comment

Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C co-infection

Melina E Santos et al. AIDS. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Costiniuk CT, Jenabian M-A. Cannabinoids and inflammation: implications for people living with HIV. AIDS 2019; 33:2273–2288.
    1. Marcellin F, Lions C, Rosenthal E, Roux P, Sogni P, Wittkop L, et al. HEPAVIH ANRS CO13 Study GroupNo significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). Drug Alcohol Rev 2016; 36:227–238.
    1. Brunet L, Moodie EEM, Rollet K, Cooper C, Walmsley S, Potter M, et al. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: A longitudinal Cohort analysis. Clin Infect Dis 2013; 57:663–670.
    1. Kelly EM, Dodge JL, Sarkar M, French AL, Tien PC, Glesby MJ, et al. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women. Clin Infect Dis 2016; 63:512–518.
    1. Marcellin F, Protopopescu C, Wittkop L, Salmon-Ceron D, Sogni P, Carrieri MP, et al. ANRS CO13 HEPAVIH Study GroupNo influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study). Eur J Gastroenterol Hepatol 2019; 31:274–276.

LinkOut - more resources